Thus, the clinical spectrum ranges from mild respiratory conditions (airways colonisation, IgE-mediated rhinitis, and/or asthma) to severe pulmonary diseases such as allergic bronchopulmonary aspergillosis (ABPA) and chronic pulmonary aspergillosis or invasive aspergillosis. This evidence concerns the gene IGHE and rhinitis.